STALFORT JOHN A III received a stock award from TAYSHA GENE THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2026ACC: 0001709418-26-000002
Director
Since Jun 2023
+64.01K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
64.01K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.34K
Price / share
—
Trade value
—
% of position
1.8%
6/1/2026
1.16M→1.18M
Total
Net shares
+21.34K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | A · Award | +21.34K | — | — | 1.8% | 1.16M | 1.18M |
| Total | +21.34K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
42.67K shares
Shares
+42.67K
Strike price
5.97
Held after
42.67K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock42.67K shares | 6/1/2026 | A · Award | +42.67K | 5.97 | — | 42.67K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned884.29K
Total
884.29K indirect884.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 884.29K | Indirect |
| Total | 884.29K | 884.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported